GlassScriptPhysician profile
Leah Terry
NPI 1750847976
$802.90
in general payments reported to CMS, 2019-2025
13 companies · $34.86 in 2025
The $34.86 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $768 · 2025: $34.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $192.61 | 2021 | |
| Amgen INC. | $124.38 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.74 | 2021 | |
| Novo Nordisk INC | $79.33 | 2021 | |
| Lilly USA, LLC | $57.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $49.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $44.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $36.33 | 2021 | |
| Galderma Laboratories, L.P. | $34.86 | 2025 | |
| Pfizer INC. | $18.40 | 2021 | |
| Horizon Therapeutics Plc | $16.37 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.81 | 2021 | |
| Nalu Medical, INC. | $13.48 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.